TR201710576A2 - Mi̇kroparti̇küler si̇stem i̇çeren anal fi̇ssür tedavi̇si̇ i̇çi̇n bi̇r tampon - Google Patents

Mi̇kroparti̇küler si̇stem i̇çeren anal fi̇ssür tedavi̇si̇ i̇çi̇n bi̇r tampon Download PDF

Info

Publication number
TR201710576A2
TR201710576A2 TR2017/10576A TR201710576A TR201710576A2 TR 201710576 A2 TR201710576 A2 TR 201710576A2 TR 2017/10576 A TR2017/10576 A TR 2017/10576A TR 201710576 A TR201710576 A TR 201710576A TR 201710576 A2 TR201710576 A2 TR 201710576A2
Authority
TR
Turkey
Prior art keywords
buffer
anal fissure
anal
microparticular
fissure treatment
Prior art date
Application number
TR2017/10576A
Other languages
English (en)
Inventor
Meri̇h Sariişik Ayşe
Yaprak Si̇nem
Rençber Seda
Önder Tolga
Ceylan Türkoğlu Gi̇zem
Original Assignee
Dokuz Eyluel Ueniversitesi Rektoerluegue
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dokuz Eyluel Ueniversitesi Rektoerluegue filed Critical Dokuz Eyluel Ueniversitesi Rektoerluegue
Priority to TR2017/10576A priority Critical patent/TR201710576A2/tr
Priority to PCT/TR2018/050377 priority patent/WO2019098958A2/en
Priority to EP18877697.5A priority patent/EP3654897A4/en
Publication of TR201710576A2 publication Critical patent/TR201710576A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/20—Tampons, e.g. catamenial tampons; Accessories therefor
    • A61F13/2002—Tampons, e.g. catamenial tampons; Accessories therefor characterised by the use
    • A61F13/2011—Tampons, e.g. catamenial tampons; Accessories therefor characterised by the use specially adapted for anal cavity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
    • A61L2300/622—Microcapsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Buluş, anorektum bölgesi hastalığı anal fissürün medikal tedavisinde kullanılan hemostatik yara iyileştirici biyostabil ve biyobozunur tamponlar ile ilgilidir. Bu anal tamponlar, kalsiyum kanal blokeri ve lokal anestezik özellikli ilaç içermektedir.
TR2017/10576A 2017-07-19 2017-07-19 Mi̇kroparti̇küler si̇stem i̇çeren anal fi̇ssür tedavi̇si̇ i̇çi̇n bi̇r tampon TR201710576A2 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2017/10576A TR201710576A2 (tr) 2017-07-19 2017-07-19 Mi̇kroparti̇küler si̇stem i̇çeren anal fi̇ssür tedavi̇si̇ i̇çi̇n bi̇r tampon
PCT/TR2018/050377 WO2019098958A2 (en) 2017-07-19 2018-07-18 Tampon for anal fissure treatment which comprises a microparticulate system
EP18877697.5A EP3654897A4 (en) 2017-07-19 2018-07-18 BUFFER FOR TREATING ANAL CRACK, COMPRISING A MICROPARTICLE SYSTEM

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/10576A TR201710576A2 (tr) 2017-07-19 2017-07-19 Mi̇kroparti̇küler si̇stem i̇çeren anal fi̇ssür tedavi̇si̇ i̇çi̇n bi̇r tampon

Publications (1)

Publication Number Publication Date
TR201710576A2 true TR201710576A2 (tr) 2019-02-21

Family

ID=66540356

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/10576A TR201710576A2 (tr) 2017-07-19 2017-07-19 Mi̇kroparti̇küler si̇stem i̇çeren anal fi̇ssür tedavi̇si̇ i̇çi̇n bi̇r tampon

Country Status (3)

Country Link
EP (1) EP3654897A4 (tr)
TR (1) TR201710576A2 (tr)
WO (1) WO2019098958A2 (tr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2281755C (en) * 1997-02-24 2006-11-07 Michael Albert Kamm Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
IL129951A0 (en) * 1997-07-02 2000-02-29 Euro Celtique Sa Prolonged anesthesia in joints and body spaces
US20060034904A1 (en) * 2002-12-31 2006-02-16 Ultra-Sonic Technologies, L.L.C. Transdermal delivery using emcapsulated agent activated by ultrasound and or heat
US9498431B2 (en) * 2008-12-10 2016-11-22 Jianjian Xu Controlled releasing composition
US20140235570A1 (en) * 2013-02-19 2014-08-21 David Jonathan Hochman Therapeutic composition for the treatment of perianal disorders

Also Published As

Publication number Publication date
WO2019098958A3 (en) 2019-08-08
EP3654897A4 (en) 2020-07-15
WO2019098958A2 (en) 2019-05-23
EP3654897A2 (en) 2020-05-27

Similar Documents

Publication Publication Date Title
EP3613355C0 (en) SURGICAL STAPLER STAPLES WITH TISSUE STOP FEATURES CONFIGURED TO PREVENT TISSUE PINCHING
BR112013021127B8 (pt) Dispositivo de implante afastador de válvula nasal bioabsorvível
BR112015027699A2 (pt) Uso de robenidina ou um sal terapeuticamente aceitável da mesma, composição farmacêutica antibacteriana e dispositivo médico
MX2019011117A (es) Anticuerpo b7-h3, fragmento de union a antigeno de los mismos y uso medico de los mismos.
BR112015027704A2 (pt) Composto, uso do mesmo e composição farmacêutica antibacteriana
BR112016002821A2 (pt) “artigo para tratamento de feridas com fibras superabsorventes e partículas superabsorventes”
BR112016002781A2 (pt) métodos e dispositivos para puncionar tecido
BR112015026006A2 (pt) métodos para o tratamento de câncer com o uso de terapia de combinação com inibidor de cinase tor
TR201901744T4 (tr) Turmalin bazlı, kadınlar ve idrar kaçırma için hijyenik havlular ve yaraların tedavisi için gazlı bezler/ bandajlar ve cerrahi pansumanlar.
MX380273B (es) Conjugados de farmacos anticuerpo (adcs) con inhibidores de ksp.
MX2016009852A (es) Sistemas para el cuidado de la piel despues del procedimiento, composiciones y metodos de uso de los mismos.
MX2020011481A (es) Dispositivo de fijacion que tiene una correa y vendaje integral.
MX376691B (es) Composición farmaceutica que comprende un antagonista de il-4r para tratar una infección cutánea.
BR112015026297A2 (pt) terapia combinada composta por um inibidor tor quinase e um composto de 5-quinazolinona substituído para o tratamento de câncer
MX376410B (es) Composición hemostática degradable.
BR112015026247A2 (pt) métodos para o tratamento de câncer com o uso de terapia combinada com inibidor de cinase tor
MX2015016381A (es) Composicion hemostatica degradable.
CO7240418A2 (es) Apósito con una liberación prolongada de agentes activos
MX2022011790A (es) Dispositivos, metodos de ingenieria de tejidos y medicina regenerativa y celular in vivo empleando andamios hechos de material absorbible.
MX2019015676A (es) Uso de isovaleril espiramicina i, ii y/o iii en la fabricación de medicamentos para el tratamiento y/o la prevención de tumores, y el medicamento.
BR112015023917A2 (pt) método para determinar a atividade de forma potenciada ativada de substância
IL290534A (en) Therapeutic systems, devices and preparations with wound healing and tissue regeneration properties, their uses and appropriate methods
BR112019001130A2 (pt) uso de lactama e composição farmacêutica
EA201990995A1 (ru) Терапия постоперационной рвоты амисульпридом
WO2019098958A3 (en) Tampon for anal fissure treatment which comprises a microparticulate system